Weigao Blood Purification
60301435.001.60% ( +0.55 )
Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Weigao Blood Purification(603014) the Revenue is 2.61 B (+168.7%);the EBIT is 747.02 M (+424.9%);the EPS is 0.505 (+85.89%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
2.61B168.65%
----
----
EBIT
0.75B424.89%
----
----
EPS
0.505585.89%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 26, 2027
Estimate Revenue4.101 B
Estimate EBIT609 M
Estimate EPS1.205
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly